Abstract:Radiotherapy is one of the mainstream approaches for cancer treatment, although the clinical outcomes are limited due to the radioresistance of tumor cells. Hypoxia and metabolic reprogramming are the hallmarks of tumor initiation and progression and are closely linked to radioresistance. Inside a tumor, the rate of angiogenesis lags behind cell proliferation, and the underdevelopment and abnormal functions of blood vessels in some loci result in oxygen deficiency in cancer cells, i.e., hypoxia. This prevents radiation from effectively eliminating the hypoxic cancer cells. Cancer cells switch to glycolysis as the main source of energy, a phenomenon known as the Warburg effect, to sustain their rapid proliferation rates. Therefore, pathways involved in metabolic reprogramming and hypoxia-induced radioresistance are promising intervention targets for cancer treatment. In this review, we discussed the mechanisms and pathways underlying radioresistance due to hypoxia and metabolic reprogramming in detail, including DNA repair, role of cancer stem cells, oxidative stress relief, autophagy regulation, angiogenesis and immune escape. In addition, we proposed the existence of a feedback loop between energy metabolic reprogramming and hypoxia, which is associated with the development and exacerbation of radioresistance in tumors. Simultaneous blockade of this feedback loop and other tumor-specific targets can be an effective approach to overcome radioresistance of cancer cells. This comprehensive overview provides new insights into the mechanisms underlying tumor radiosensitivity and progression.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: how to overcome the radioresistance of tumor cells in radiotherapy, especially the radioresistance caused by hypoxia and metabolic reprogramming. Radiotherapy is one of the main methods for cancer treatment, but its clinical effect is limited due to the radioresistance of tumor cells. Hypoxia and metabolic reprogramming are important characteristics of tumorigenesis and development and are closely related to radioresistance. The paper discusses in detail the mechanisms by which hypoxia and metabolic reprogramming lead to radioresistance, including aspects such as DNA repair, the role of cancer stem cells, oxidative stress alleviation, autophagy regulation, angiogenesis, and immune escape, and proposes that simultaneously blocking the feedback loop between energy - metabolic reprogramming and hypoxia and other tumor - specific targets may be an effective strategy to overcome radioresistance. Specifically, the paper explores the following aspects: 1. **DNA damage repair**: Radiation mainly kills cells by causing single - strand breaks (SSBs), double - strand breaks (DSBs), base and sugar damage, and cross - linking in DNA, among which DSBs are the most lethal. The activation of the DNA damage repair (DDR) pathway is a major reason for promoting radioresistance. Under hypoxic conditions, the activation of AMPK enhances the DSB repair ability through ATM and DNA - PKcs, thereby increasing radioresistance. 2. **The role of cancer stem cells (CSCs)**: CSCs are a small fraction of tumor cells with self - renewal and multi - directional differentiation abilities and are mainly located in nutrient - deficient and hypoxic tumor areas. These cells are highly resistant to radiotherapy and chemotherapy and are the seed cells for tumor recurrence and metastasis. 3. **Oxidative stress alleviation**: Radiation triggers the production of reactive oxygen species (ROS) and oxidative stress in tumor cells, leading to DNA damage. Under hypoxic conditions, HIF - 1 increases the glutathione (GSH) level and enhances radioresistance. 4. **Autophagy regulation**: Autophagy is a process of cellular autophagy that can promote cell survival or lead to cell death. Under hypoxic conditions, the activation of autophagy accelerates the clearance of intracellular ROS and enhances radioresistance. 5. **Angiogenesis and immune escape**: Under hypoxic conditions, tumor cells secrete multiple factors to promote angiogenesis and immune escape, further enhancing radioresistance. By deeply understanding these mechanisms, the paper provides new insights for the development of new radiotherapy strategies.

Feedback loop between hypoxia and energy metabolic reprogramming aggravates the radioresistance of cancer cells

Myriad factors and pathways influencing tumor radiotherapy resistance

Novel insight into metabolic reprogrammming in cancer radioresistance: A promising therapeutic target in radiotherapy

Targeting Hypoxia, HIF-1, and Tumor Glucose Metabolism to Improve Radiotherapy Efficacy

Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance

Hypoxia-Driven Effects in Cancer: Characterization, Mechanisms, and Therapeutic Implications

Molecular mechanisms of tumor resistance to radiotherapy

Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities

Targeting Mitochondrial Metabolism to Reverse Radioresistance: An Alternative to Glucose Metabolism

Hypoxia Boosts Aerobic Glycolysis in Carcinoma: A Complex Process for Tumour Development

Tumor Hypoxia: Impact on Radiation Therapy and Molecular Pathways

Role of hypoxia in cancer therapy by regulating the tumor microenvironment

The cellular-centered view of hypoxia tumor microenvironment: Molecular mechanisms and therapeutic interventions

Hypoxic tumor microenvironment: Implications for cancer therapy

PI3K/AKT/mTOR Pathway, Hypoxia, and Glucose Metabolism: Potential Targets to Overcome Radioresistance in Small Cell Lung Cancer

Hypoxia and Cancer Cell Metabolism

Autophagy Enhanced the Radioresistance of Non-Small Cell Lung Cancer by Regulating ROS Level under Hypoxia Condition

Reprogramming of the Tumor in the Hypoxic Niche: The Emerging Concept and Associated Therapeutic Strategies

Radiotherapy modulates tumor cell fate decisions: a review

Central role of hypoxia-inducible factor-1α in metabolic reprogramming of cancer cells: A review

HIF-1-Dependent Reprogramming of Glucose Metabolic Pathway of Cancer Cells and Its Therapeutic Significance